Jamieson is pleased to announce that it has advised the management team of Ris Rx in connection with the growth investment from Summit Partners. The investment will support Ris Rx’s continued innovation to improve patient’s access to treatment.
Ris Rx is a healthcare technology company focused on technology solutions to reduce revenue leakage in pharmaceutical gross-to-net spread. RIS Rx’s platform includes targeted solutions designed to address key vulnerabilities in affordability program operations with accuracy and speed.
Evan Alper and Matthew Schwarcz advised founders Gerard Rivera and Stephen Hom and the rest of the management team at Ris Rx on their equity investment and management incentive plan in the new structure.
Jamieson Corporate Finance US, LLC is a member of FINRA/SIPC.
